New injection tested to fight Pre-Cancer before it spreads
NCT ID NCT07408856
Summary
This early-stage study is testing the safety of a new drug called CAN1012, which is injected directly into pre-cancerous lesions in the mouth or breast. It involves about 60 adults who are already scheduled to have these lesions surgically removed. The main goal is to see if the injection is safe and doesn't cause delays to the planned surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCTAL CARCINOMA IN SITU are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Providence Portland Cancer Institute - Franz Clinic
Portland, Oregon, 97213, United States
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.